Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
SUBMITTER: Xabier Agirre
PROVIDER: E-GEOD-26807 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Leukemia 20120206 7
Histone deacetylases (HDACs) have been identified as therapeutic targets due to their regulatory function in chromatin structure and organization. Here, we analyzed the therapeutic effect of LBH589, a class I-II HDAC inhibitor, in acute lymphoblastic leukemia (ALL). In vitro, LBH589 induced dose-dependent antiproliferative and apoptotic effects, which were associated with increased H3 and H4 histone acetylation. Intravenous administration of LBH589 in immunodeficient BALB/c-RAG2(-/-)γc(-/-) mice ...[more]